Correlation Between Larimar Therapeutics and Traws Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Traws Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Traws Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Traws Pharma, you can compare the effects of market volatilities on Larimar Therapeutics and Traws Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Traws Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Traws Pharma.

Diversification Opportunities for Larimar Therapeutics and Traws Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Larimar and Traws is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Traws Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Traws Pharma and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Traws Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Traws Pharma has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Traws Pharma go up and down completely randomly.

Pair Corralation between Larimar Therapeutics and Traws Pharma

If you would invest  0.00  in Traws Pharma on October 4, 2024 and sell it today you would earn a total of  0.00  from holding Traws Pharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.61%
ValuesDaily Returns

Larimar Therapeutics  vs.  Traws Pharma

 Performance 
       Timeline  
Larimar Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Larimar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Traws Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Traws Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Traws Pharma is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Larimar Therapeutics and Traws Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Larimar Therapeutics and Traws Pharma

The main advantage of trading using opposite Larimar Therapeutics and Traws Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Traws Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will offset losses from the drop in Traws Pharma's long position.
The idea behind Larimar Therapeutics and Traws Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years